66 results on '"O’Toole, Á"'
Search Results
2. Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer
3. Pathologist initiated reflex BRAF mutation testing in metastatic melanoma: experience at a specialist melanoma treatment centre
4. ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1
5. BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting
6. Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation
7. The molecular profile of metastatic melanoma in Australia
8. Mammary analogue secretory carcinoma: an evaluation of its clinicopathological and genetic characteristics
9. EGFR mutation specific immunohistochemistry is a useful adjunct which helps to identify false negative mutation testing in lung cancer
10. Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer
11. Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas
12. Classification, morphology and molecular pathology of premalignant lesions of the pancreas
13. An unusual case of invasive lobular carcinoma with abundant extracellular mucin
14. Molecular assays in breast cancer pathology
15. What’s new in non-small cell lung cancer for pathologists the importance of accurate subtyping, EGFR mutations and ALK rearrangements
16. Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma
17. The dangers of weight-loss surgery. A case-series of severe metabolic dysfunction associated steatohepatitis following bariatric surgery
18. Acute Epstein–Barr virus hepatitis superimposed on drug induced liver injury causing severe hepatic dysfunction
19. Gynaecomastia-like hyperplasia of axillary ectopic breast tissue – a case report
20. Evidence for lymphatic pathogenesis of endosalpingiosis
21. 9. Factors influencing the success rate of patient derived xenograft formation from breast cancer specimens
22. Immunohistochemical analysis of potential tumour markers in fibroepithelial neoplasms of the breast: does protein expression align with genomic data?
23. The bleeding obvious – a case of male endometriosis
24. Using the epigenome to understand and better classify phyllodes tumours
25. Examples of the diagnostic utility of USP6 FISH in soft tissue and bone pathology
26. Somatic mutations in salivary duct carcinoma and potential therapeutic targets
27. Cancer mutation profiling in ffpe samples: a comparison study of mass spectrometry (MS) and next generation sequencing (NGS) analyses
28. A first look at the genomic landscape of non-metastatic cutaneous squamous cell carcinoma
29. Inflammatory myofibroblastic tumours of the head and neck
30. PDl1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome
31. Diagnostic and prognostic utility of MYB gene rearrangement detected by fluorescent in-situ hybridisation (FISH) in adenoid cystic carcinoma
32. BRAF (v600e) and NRAS (q61r/q61l) mutation analysis using immunohistochemistry: Implications for routine mutation testing of melanoma samples
33. Targeted next generation sequencing in FFPE samples of NSCLC
34. A case report of invasive ductal carcinoma of the breast with prominent sebaceous differentiation
35. What do i need to know about somatic mutation testing as a tissue pathologist – A survival guide?
36. Diagnostic and prognostic utility of mastermind-like 2 (MAML2) gene rearrangement detected by fluorescent in-situ hybridisation (Fish) in mucoepidermoid carcinoma
37. Mammary analogue secretory carcinoma: an evaluation of its genetic and clinical characteristics
38. Exploring salivary duct carcinoma: clinicopathologic features, morphologic spectrum and genetic changes
39. 37. Mutation testing in non-small cell lung cancer - suitability of small biopsy and cytology specimens
40. 18. A case report of invasive ductal carcinoma of the breast with prominent sebaceous differentiation
41. 11. ROS1 gene rearrangements in non-small cell lung carcinoma - A new genetic target
42. MET Copy number in triple negative breast cancers
43. Fluorescent in situ hybridisation: A novel approach to salivary gland tumours
44. Candidate methylation profiling of ductal carcinoma in situ and its relationship to phenotype
45. BRAF mutations in non-small cell lung cancer - A rare targetable driver mutation
46. 31. EWSR1 FISH – an assessment of complex signal patterns
47. 6. Patterns of somatic mutations in nine cases of metaplastic carcinoma of the breast
48. TFE3 FISH assessment in renal cell carcinomas
49. Evaluation of anaplastic lymphoma kinase (ALK) rearrangements using ALK/EML4 tricheck fluorescence in situ hybridisation (FISH) in non-small cell lung cancers (NSCLC)
50. A lack of actionable mutations in phyllodes tumours of the breast
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.